Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study

Kristian Reich, Claire Clibborn, Kim Papp et al.|Journal of the European Academy of Dermatology and Venereology|2023

Cited by 47